<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03748342</url>
  </required_header>
  <id_info>
    <org_study_id>STU-112017-050</org_study_id>
    <nct_id>NCT03748342</nct_id>
  </id_info>
  <brief_title>Second Generation LMA Versus Endotracheal Tube in Obese Patients</brief_title>
  <official_title>The Use of a Second-Generation Laryngeal Mask Airway Versus Endotracheal Tube in Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas Southwestern Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized, comparative study is intended to enroll a total of 148 patients
      with a BMI 30-49.9 kg/m2 undergoing surgery at Parkland Hospital. The efficacy and
      performance of a second-generation LMA will be compared to endotracheal intubation. A
      standardized anesthetic protocol that is usual and customary for the type of operation the
      patient is having will be provided to the anesthesia teams of enrolled subjects. The
      remainder of the anesthetic care of the subject will not deviate from the standard of care.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 27, 2019</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative hypoxia</measure>
    <time_frame>Up to 80 minutes post-operatively</time_frame>
    <description>Patients in the 2 groups will be assessed for postoperative hypoxia in the PACU using a visual analog scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alterations in blood pressure</measure>
    <time_frame>Intra-operatively</time_frame>
    <description>Blood pressure monitor readings will be recorded throughout the surgery and compared to baseline pre-operative values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alterations in heart rate</measure>
    <time_frame>Intra-operatively</time_frame>
    <description>Heart rate monitor readings will be recorded throughout the surgery and compared to baseline pre-operative values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alterations in oxygen saturation</measure>
    <time_frame>Intra-operatively</time_frame>
    <description>Oxygen saturation readings will be recorded throughout the surgery and compared to baseline pre-operative values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alterations in respiratory rate</measure>
    <time_frame>Intra-operatively</time_frame>
    <description>Respiratory rate readings will be recorded throughout the surgery and compared to baseline pre-operative values.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">97</enrollment>
  <condition>Obese</condition>
  <condition>Endotracheal Tube</condition>
  <condition>Laryngeal Mask Airway</condition>
  <arm_group>
    <arm_group_label>Standard Endotracheal Tube</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Second-Generation LMA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Second-Generation Laryngeal Mask Airway</intervention_name>
    <description>A second-generation LMA will be used for airway management (instead of ETT).</description>
    <arm_group_label>Second-Generation LMA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-80 years old

          -  Obese (BMI &gt; or equal to 30 kg/m2

          -  Scheduled for a non-emergent surgery that requires general anesthesia (e.g.,
             orthopedic, breast, urological, colorectal, ENT, vascular, general surgery)

          -  Willing and able to consent in English or Spanish

          -  No current history of advanced pulmonary or cardiac disease

        Exclusion Criteria:

          -  Age less than 18 or older than 80

          -  BMI â‰¥50 or &lt; 30 kg/m2

          -  Patient does not speak English or Spanish

          -  Expected surgical duration longer than 4 hours

          -  Planned postoperative ICU admission

          -  Patient refusal

          -  Monitored anesthesia care (MAC) or regional anesthesia planned

          -  Pregnant or nursing women

          -  &quot;Stat&quot; (emergent) cases

          -  Known or suspected difficult airway

          -  Full stomach/significant aspiration risk (gastroparesis, emergency surgery, untreated
             moderate to severe gastroesophageal reflux disease, hiatal hernia)

          -  No history of gastric surgery

          -  Surgery in position other than supine (e.g., Trendelenburg)

          -  Laparoscopic surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Parkland Health &amp; Hospital System</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>November 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2018</study_first_posted>
  <last_update_submitted>April 5, 2020</last_update_submitted>
  <last_update_submitted_qc>April 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas Southwestern Medical Center</investigator_affiliation>
    <investigator_full_name>Tiffany B Moon</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

